Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
This start low and go slow approach helps minimize side effects
Why Injections Rather Than Oral Supplements
Have Digestive Disorders: Conditions such as Crohns disease or coeliac disease can impair the absorption of B12 from food
It is resistant to enzymatic digestion in research conditions and has demonstrated activity across multiple tissue systems in a broad published literature base
What This Means Clinically For patients who have tried GLP-1 medications and experienced significant side effects, or who are not candidates for appetite-suppressing approaches, AOD 9604 represents a mechanistically different option
